Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Køber, Lars"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 151
Tytuł:
Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation.
Autorzy:
Omerovic E; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna Stråket 16, 41345, Gothenburg, Sweden. .
Petrie M; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Redfors B; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna Stråket 16, 41345, Gothenburg, Sweden.
Fremes S; Department of Surgery, University of Toronto, Toronto, ON, Canada.; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Sunnybrook Research Institute, Toronto, ON, Canada.
Murphy G; Cardiovascular Research Centre, University of Leicester, Glenfield Hospital, Groby Road, Leicester, LE3 9QP, UK.
Marquis-Gravel G; Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.
Lansky A; Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Velazquez E; Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Perera D; British Heart Foundation Centre of Research Excellence and National Institute for Health and Care Research Biomedical Research Centre at the School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.
Reid C; Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Kent Street, Bentley, WA, 6102, Australia.
Smith J; Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, VIC, Australia.; Department of Cardiothoracic Surgery, Monash Health, Melbourne, VIC, Australia.
van der Meer P; Department of Cardiology, Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Lipsic E; Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Juni P; Oxford Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3 7LF, UK.
McMurray J; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Canada.
Doenst T; Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, University Hospital, Jena, Germany.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Jan 23; Vol. 25 (1), pp. 80. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Review; Letter
MeSH Terms:
Research Design*
Administrative Personnel*
Humans ; Randomized Controlled Trials as Topic ; Sample Size ; Evidence-Based Medicine
Recenzja
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction: Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiography.
Autorzy:
Krogager ML
Skals RK
Appel EVR
Schnurr TM
Engelbrechtsen L
Have CT
Pedersen O
Engstrøm T
Roden DM
Gislason G
Poulsen HE
Køber L
Stender S
Hansen T
Grarup N
Andersson C
Torp-Pedersen C
Weeke PE
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 26; Vol. 18 (10), pp. e0293765. Date of Electronic Publication: 2023 Oct 26 (Print Publication: 2023).
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rehospitalisations, repeated aortic surgery, and death in initial survivors of surgery for Stanford type A aortic dissection and the significance of age - a nationwide registry-based cohort study.
Autorzy:
Gundlund A; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 3, 2100 Copenhagen, Denmark.; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Hospitalsvej 1, 2820 Gentofte, Denmark.
Køber L; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 3, 2100 Copenhagen, Denmark.
Høfsten DE; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 3, 2100 Copenhagen, Denmark.
Vester-Andersen M; Department of Anesthesiology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Borgmester Ibs Juuls vej 1, 2730 Herlev, Denmark.
Pedersen MW; Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.
Torp-Pedersen C; Department of Cardiology, Nordsjællands Hospital, 3400 Hillerød, Denmark.; Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.; Department of Public Health, University of Copenhagen, 1165, CopenhagenDenmark.
Kragholm K; Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.
Søgaard P; Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.
Smerup M; Department of thoracic surgery, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 3, 2100 Copenhagen, Denmark.
Fosbøl EL; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 3, 2100 Copenhagen, Denmark.
Pokaż więcej
Źródło:
European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2023 Aug 07; Vol. 9 (5), pp. 520-528.
Typ publikacji:
Journal Article
MeSH Terms:
Patient Readmission*
Aortic Dissection*/surgery
Humans ; Middle Aged ; Aged ; Cohort Studies ; Aorta, Thoracic/surgery ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Coronary Artery Disease in Persons With Human Immunodeficiency Virus Without Detectable Viral Replication.
Autorzy:
Knudsen AD; Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Fuchs A; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Benfield T; Department of Infectious Diseases, Copenhagen University Hospital-Amager and Hvidovre, 2650 Hvidovre.
Gerstoft J; Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Køber L; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Trøseid M; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, University of Oslo, Oslo, Norway.
Kofoed KF; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Nielsen SD; Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 May 31; Vol. 10 (7), pp. ofad298. Date of Electronic Publication: 2023 May 31 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study.
Autorzy:
Begun X; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Butt JH; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kristensen SL; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Weeke PE; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
De Backer O; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Loldrup Fosbøl E; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Mar 16; Vol. 18 (3), pp. e0282636. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Transcatheter Aortic Valve Replacement*/adverse effects
Aortic Valve Stenosis*/drug therapy
Aortic Valve Stenosis*/surgery
Aortic Valve Stenosis*/complications
Heart Valve Prosthesis Implantation*/adverse effects
Humans ; Furosemide/therapeutic use ; Aftercare ; Risk Factors ; Patient Discharge ; Sodium Potassium Chloride Symporter Inhibitors/therapeutic use ; Denmark/epidemiology ; Treatment Outcome ; Aortic Valve/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial.
Autorzy:
Fuchs Andersen C; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.
Omar M; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Steno Diabetes Center Odense, Odense, Denmark.
Glenthøj A; Department of Haematology, Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
El Fassi D; Department of Haematology, Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Møller HJ; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Lindholm Kurtzhals JA; Department of Clinical Microbiology, Centre of Medical Parasitology, Copenhagen University Hospital, Copenhagen, Denmark.
Styrishave B; Toxicology and Drug Metabolism Group, Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
Kistorp C; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark.
Tuxen C; Department of Cardiology, Bispebjerg and Frederiksberg University Hospital, Copenhagen, Denmark.
Poulsen MK; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Faber J; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Internal Medicine, Centre of Endocrinology and Metabolism, Herlev and Gentofte University Hospital, Herlev, Denmark.
Køber L; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Internal Medicine, Centre of Endocrinology and Metabolism, Herlev and Gentofte University Hospital, Herlev, Denmark.
Gustafsson F; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Møller JE; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Schou M; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Jensen J; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2023 Feb; Vol. 25 (2), pp. 226-234. Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Diabetes Mellitus, Type 2*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Ventricular Dysfunction, Left*/drug therapy
Renal Insufficiency, Chronic*
Humans ; Male ; Stroke Volume ; Ventricular Function, Left ; Erythropoiesis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence and Mortality of Infective Endocarditis in Community-Acquired and Healthcare-Associated Staphylococcus aureus Bacteremia: A Danish Nationwide Registry-Based Cohort Study.
Autorzy:
Østergaard L; The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Regionshospital Nord, Hjørring, Denmark.
Voldstedlund M; Statens Serum Institut, Copenhagen, Denmark.
Bruun NE; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.; Department of Cardiology, Herlev-Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.; Clinical Institutes, Copenhagen and Aalborg University, Aalborg, Denmark.
Bundgaard H; The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Iversen K; Department of Cardiology, Herlev-Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Køber N; Department of Cardiology, Regionshospital Nord, Hjørring, Denmark.
Dahl A; Department of Cardiology, Herlev-Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Chamat-Hedemand S; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.; Department of Cardiology, Herlev-Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Petersen JK; The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Jensen AD; The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Christensen JJ; Regional Department of Clinical Microbiology, Zealand University Hospital, Køge and Institute of Clinical Medicine, University of Copenhagen, Køge, Denmark.
Rosenvinge FS; Department of Clinical Microbiology, Odense University Hospital and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark.
Jarløv JO; Department of Clinical Microbiology, Herlev-Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Moser C; Department of Clinical Microbiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Denmark and Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Andersen CØ; Department of Clinical Microbiology, Amager-Hvidovre Hospital, Copenhagen, Denmark.
Coia J; Department of Clinical Microbiology, Hospital of South-west Jutland and Institute for Regional Health Research University of South Denmark, Esbjerg, Denmark.
Marmolin ES; Department of Clinical Microbiology, Vejle Hospital, Vejle, Denmark.
Søgaard KK; Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Lemming L; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
Køber L; The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Fosbøl EL; The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Dec 16; Vol. 9 (12), pp. ofac647. Date of Electronic Publication: 2022 Dec 16 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term effects of cardiac rehabilitation after heart valve surgery - results from the randomised CopenHeart VR trial.
Autorzy:
Sibilitz KL; Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Tang LH; REHPA - The Danish Knowledge Centre for Rehabilitation and Palliative Care and University of Southern Denmark, Odense, Denmark.; Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Region Zealand, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Berg SK; Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Thygesen LC; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
Risom SS; Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Institute for Nursing and Nutrition, University College Copenhagen, Tagensvej, Denmark.
Rasmussen TB; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Herlev and Gentofte University Hospital, Copenhagen, Denmark.
Schmid JP; Swiss Cardiovascular Centre Bern, Cardiovascular Prevention and Rehabilitation Unit, University Hospital, Bern, Switzerland.
Borregaard B; Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark.; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Hassager C; Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Køber L; Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Taylor RS; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.; Institute of Health and Well Being, University of Glasgow, Glasgow, UK.; Institute of Health Research, University of Exeter Medical School, Exeter, UK.
Zwisler AD; REHPA - The Danish Knowledge Centre for Rehabilitation and Palliative Care and University of Southern Denmark, Odense, Denmark.; Department of Cardiology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
Scandinavian cardiovascular journal : SCJ [Scand Cardiovasc J] 2022 Dec; Vol. 56 (1), pp. 247-255.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Cardiac Rehabilitation*/adverse effects
Cardiac Rehabilitation*/methods
Cardiac Surgical Procedures*/adverse effects
Virtual Reality*
Exercise Therapy/adverse effects ; Heart Valves/surgery ; Humans ; Male ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF.
Autorzy:
Adamson C; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Cowan LM; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, Groningen, The Netherlands.
Diez M; Division of Cardiology, Institute Cardiovascular de Buenos Aires, Buenos Aires, Argentina.
Drożdż J; Department Cardiology, Medical University of Lodz, Lodz, Poland.
Dukát A; Fifth Department of Internal Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO, USA.; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
Ljungman CEA; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina.
Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland.
Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Boulton DW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA.
Greasley PJ; Early Research and Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1856-1868. Date of Electronic Publication: 2022 Aug 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Humans ; Stroke Volume ; Ventricular Function, Left ; Bilirubin ; Liver
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial.
Autorzy:
Bundgaard JS; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. .
Iversen K; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Pries-Heje M; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Ihlemann N; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Gill SU; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Madsen T; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Elming H; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
Povlsen JA; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Bruun NE; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.; Institute of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.; Clinical Institute, Aalborg University, Aalborg, Denmark.
Høfsten DE; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Fuursted K; Department of Bacteria, Parasites and Fungi, Statens Serum Institute, Copenhagen, Denmark.
Christensen JJ; The Regional Department of Clinical Microbiology, Region Zealand Slagelse Hospital, Region Zealand, Denmark.
Schultz M; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.
Rosenvinge F; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Helweg-Larsen J; Department of Infectious Diseases, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Køber L; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Torp-Pedersen C; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.; Department of Cardiology, Nordsjaellands Hospital, Hillerød, Denmark.
Fosbøl EL; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Tønder N; Department of Cardiology, North Zealand University Hospital, Hillerød, Denmark.
Moser C; Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Bundgaard H; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Mogensen UM; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
Pokaż więcej
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2022 Sep; Vol. 31 (9), pp. 2655-2662. Date of Electronic Publication: 2022 Mar 29.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Endocarditis*
Quality of Life*/psychology
Aged ; Female ; Health Status ; Humans ; Male ; Proportional Hazards Models ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectives.
Autorzy:
Jensen J; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.
Omar M; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
Kistorp C; Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Gustafsson F; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Møller JE; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Schou M; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2022 Jul; Vol. 131 (1), pp. 5-17. Date of Electronic Publication: 2022 May 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Symporters*/pharmacology
Symporters*/therapeutic use
Benzhydryl Compounds/adverse effects ; Glucose/therapeutic use ; Humans ; Sodium ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potential role of conventional and speckle-tracking echocardiography in the screening of structural and functional cardiac abnormalities in elderly individuals: Baseline echocardiographic findings from the LOOP study.
Autorzy:
Olsen FJ; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Cardiology, Zealand University Hospital, University of Copenhagen, Roskilde, Denmark.
Diederichsen SZ; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Jørgensen PG; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
Jensen MT; Department of Cardiology, Copenhagen University Hospital-Amager and Hvidovre Hospital, Hvidovre, Denmark.; Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Dahl A; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
Landler NE; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
Graff C; Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
Brandes A; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Krieger D; University Hospital Zurich, University of Zurich, Zürich, Switzerland.; Stroke Unit, Mediclinic City Hospital, Dubai, UAE.
Haugan K; Department of Cardiology, Zealand University Hospital, University of Copenhagen, Roskilde, Denmark.
Køber L; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Højberg S; Department of Cardiology, Copenhagen University Hospital-Frederiksberg and Bispebjerg Hospital, Copenhagen, Denmark.
Svendsen JH; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Biering-Sørensen T; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jun 03; Vol. 17 (6), pp. e0269475. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).
Typ publikacji:
Journal Article; Observational Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Calcinosis*
Heart Defects, Congenital*
Ventricular Dysfunction, Left*
Aged ; Echocardiography ; Heart Atria ; Humans ; Ventricular Function, Left ; Ventricular Remodeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF.
Autorzy:
McDowell K; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Welsh P; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Morrow DA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, Groningen, The Netherlands.
O'Meara E; Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO, USA.; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina.
Ponikowski P; Centre for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland.
Hammarstedt A; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.
Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.
Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.
Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, Astrazeneca, Gothenburg, Sweden.
Solomon SD; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Sattar N; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Sabatine MS; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jun; Vol. 24 (6), pp. 1066-1076. Date of Electronic Publication: 2022 Feb 06.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/complications
Ventricular Dysfunction, Left*/complications
Aged ; Benzhydryl Compounds ; Female ; Glucosides/pharmacology ; Humans ; Male ; Middle Aged ; Stroke Volume ; Uric Acid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Temporal patterns of multi-morbidity in 570157 ischemic heart disease patients: a nationwide cohort study.
Autorzy:
Haue AD; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.; Department of Cardiology, The Heart Center, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Armenteros JJA; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
Holm PC; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
Eriksson R; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.; Department of Infectious Diseases, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Moseley PL; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.; College of Health Solutions, Arizona State University, Arizona State University, 550 N 3rd St., Phoenix, AZ, 85004, USA.
Køber LV; Department of Cardiology, The Heart Center, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
Bundgaard H; Department of Cardiology, The Heart Center, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark. .; Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2022 May 31; Vol. 21 (1), pp. 87. Date of Electronic Publication: 2022 May 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation*
Heart Failure*/diagnosis
Heart Failure*/epidemiology
Myocardial Ischemia*/diagnosis
Myocardial Ischemia*/epidemiology
Osteoarthritis*
Cohort Studies ; Humans ; Multimorbidity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rate.
Autorzy:
Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Adamson C; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Vaduganathan M; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, MN, USA.
Zannad F; Université de Lorraine, Centre d'Investigation Clinique-Plurithématique Inserm CIC-P 1433, Nancy, France Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
Køber L; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 May; Vol. 24 (5), pp. 861-866. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Failure*/drug therapy
Heart Failure*/epidemiology
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/epidemiology
Creatinine ; Female ; Glomerular Filtration Rate ; Humans ; Male ; Middle Aged ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial.
Autorzy:
Johansen ND; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Modin D; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Nealon J; Influenza Medical Evidence Generation, Sanofi Pasteur, Lyon, France.; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Special Administrative Region, China.
Samson S; Global Medical Affairs, Sanofi Pasteur, Lyon, France.
Salamand C; Clinical Department, Biostatistical Sciences, Sanofi Pasteur, Lyon, France.
Larsen CS; Department of Clinical Medicine - Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Landray MJ; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Public Health, University of Oxford, Oxford, UK.; Big Data Institute, University of Oxford, Oxford, UK.
Gislason GH; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; The Danish Heart Foundation, Copenhagen, Denmark.; The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
Køber L; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Jensen JUS; Respiratory Medicine Section, Department of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Sivapalan P; Respiratory Medicine Section, Department of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Vestergaard LS; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Valentiner-Branth P; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Krause TG; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Biering-Sørensen T; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark. .; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. .
Pokaż więcej
Źródło:
Pilot and feasibility studies [Pilot Feasibility Stud] 2022 Apr 21; Vol. 8 (1), pp. 87. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF.
Autorzy:
Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, Groningen, The Netherlands.
Böhm M; Department of Internal Medicine III, Saarland University Hospital, Saarland University, Homburg, Germany.
Desai AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Howlett JG; Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, Calgary, Canada.
Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina.
Nicolau JC; Instituto do Coracao (InCor), Hospital das Clínicas Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Petrie MC; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wrocław, Poland.
Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark.
Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Sabatine MS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Køber L; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Mar; Vol. 24 (3), pp. 513-525. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Heart Failure*/complications
Heart Failure*/drug therapy
Benzhydryl Compounds ; Glucosides/pharmacology ; Glucosides/therapeutic use ; Humans ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
Autorzy:
Jackson AM; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Heart Centre, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Liu J; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Heart Centre, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Anand IS; University of Minnesota, Minneapolis, MN, USA.
Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Cleland JGF; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Chopra VK; Max Super Speciality Hospital, Saket, New Delhi, India.
Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Ge J; Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
Gong J; Novartis Pharmaceuticals, East Hanover, NJ, USA.
Lam CSP; National Heart Center Singapore and Duke-National University of Singapore, Singapore, Singapore.; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Lefkowitz MP; Novartis Pharmaceuticals, East Hanover, NJ, USA.
Maggioni AP; National Association of Hospital Cardiologists Research Center, Florence, Italy.
Martinez F; National University of Cordoba, Cordoba, Argentina.
Packer M; Baylor University Medical Center, Dallas, TX, USA.
Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Pieske B; Department of Internal Medicine and Cardiology, German Center for Cardiovascular Research partner site Berlin, Berlin, Germany.
Redfield MM; Mayo Clinic, Rochester, MN, USA.
Rizkala AR; Novartis Pharmaceuticals, East Hanover, NJ, USA.
Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montreal, Canada.
Seferović PM; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Tromp J; National Heart Center Singapore and Duke-National University of Singapore, Singapore, Singapore.; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Yilmaz MB; Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Zannad F; INSERM Centre d'Investigation Clinic 1433 and Universite de Lorraine, Centre Hospitalier Regional et Universitaire, Nancy, France.
Zile MR; Medical University of South Carolina and the Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, USA.
Køber L; Heart Centre, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Corporate Authors:
PARAGON-HF Committees and Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Mar; Vol. 24 (3), pp. 497-509. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Diabetes Mellitus*/epidemiology
Heart Failure*/drug therapy
Prediabetic State*/epidemiology
Humans ; Middle Aged ; Natriuretic Peptide, Brain/therapeutic use ; Peptide Fragments/therapeutic use ; Prognosis ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker).
Autorzy:
Omar M; Department of Cardiology, Research Unit of Cardiology, Odense University Hospital, Odense, Denmark. .; Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. .; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. .
Jensen J; Department of Cardiology, Herlev, Gentofte University Hospital, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Kistorp C; Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Højlund K; Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
Videbæk L
Tuxen C; Department of Cardiology, Bispebjerg, Frederiksberg University Hospital, Copenhagen, Denmark.
Larsen JH; Department of Cardiology, Research Unit of Cardiology, Odense University Hospital, Odense, Denmark.
Andersen CF; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Gustafsson F; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Schou M; Department of Cardiology, Herlev, Gentofte University Hospital, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Møller JE; Department of Cardiology, Research Unit of Cardiology, Odense University Hospital, Odense, Denmark.; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Feb 27; Vol. 21 (1), pp. 34. Date of Electronic Publication: 2022 Feb 27.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/chemically induced
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*/diagnosis
Heart Failure*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Aged ; Benzhydryl Compounds/adverse effects ; Biomarkers ; Double-Blind Method ; Female ; Glucosides ; Growth Differentiation Factor 15 ; Humans ; Male ; Middle Aged ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
De novo electrocardiographic abnormalities in persons living with HIV.
Autorzy:
Knudsen AD; Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Blegdamsvej 9B, 2100, Copenhagen, Denmark.; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Graff C; Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
Nielsen JB; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Thomsen MT; Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Blegdamsvej 9B, 2100, Copenhagen, Denmark.
Høgh J; Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Blegdamsvej 9B, 2100, Copenhagen, Denmark.
Benfield T; Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
Gerstoft J; Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Blegdamsvej 9B, 2100, Copenhagen, Denmark.
Køber L; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Kofoed KF; Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Nielsen SD; Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Blegdamsvej 9B, 2100, Copenhagen, Denmark. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Oct 21; Vol. 11 (1), pp. 20750. Date of Electronic Publication: 2021 Oct 21.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*physiopathology
Heart/*physiopathology
Long QT Syndrome/*physiopathology
Adult ; Alkynes/adverse effects ; Alkynes/therapeutic use ; Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; Benzoxazines/adverse effects ; Benzoxazines/therapeutic use ; Cyclopropanes/adverse effects ; Cyclopropanes/therapeutic use ; Electrocardiography ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; Heart/drug effects ; Heart Disease Risk Factors ; Humans ; Incidence ; Long QT Syndrome/etiology ; Male ; Middle Aged ; Protease Inhibitors/adverse effects ; Protease Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 151

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies